Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Guangdong Multiple Myeloma Active Trials & Centers
As of 2026-10-21, there are 44 active clinical trials for multiple myeloma hosted across 34 tertiary medical centers in Guangdong (including Sun Yat-sen University Cancer Center, Peking University Shenzhen Hospital, Nanfang Hospital, Southern Medical University, etc.).
Participating Medical Centers (34)
Active Studies in Guangdong (44)
Population synthesized by CMDNShowing 0 published English records of 44 registry trials.
All 44 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.
